Sava, Gianni
Università degli Studi di Trieste,
Italy
2025 Rank: 225717
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 7036 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 225717 | 247786 |
| Total Cites | 388 | 401 |
| H-index | 10 | 10 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 74 | 74 |
| Total Cites to Single+First Authored Papers | 48 | 48 |
| Number of Single+First+Last Authored Papers | 158 | 158 |
| Total Cites to Single+First+Last Authored Papers | 228 | 233 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 268 | 274 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.46 |
| Self-Citation Percentage |
3.24%
|
|
Sava, Gianni
Università degli Studi di Trieste,
Italy
2024 Rank: 132701
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 4326 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 132701 | 138591 |
| Total Cites | 444 | 480 |
| H-index | 10 | 10 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 75 | 75 |
| Total Cites to Single+First Authored Papers | 71 | 81 |
| Number of Single+First+Last Authored Papers | 158 | 158 |
| Total Cites to Single+First+Last Authored Papers | 254 | 272 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 302 | 314 |
| Ratio of Total Citations to Distinct Citing Papers | 1.47 | 1.53 |
| Self-Citation Percentage |
7.50%
|
|
Sava, Gianni
Università degli Studi di Trieste,
Italy
2023 Rank: 129301
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 4585 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 129301 | 151548 |
| Total Cites | 557 | 572 |
| H-index | 12 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 75 | 75 |
| Total Cites to Single+First Authored Papers | 56 | 56 |
| Number of Single+First+Last Authored Papers | 157 | 157 |
| Total Cites to Single+First+Last Authored Papers | 316 | 317 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 352 | 362 |
| Ratio of Total Citations to Distinct Citing Papers | 1.58 | 1.58 |
| Self-Citation Percentage |
2.62%
|
|
Sava, Gianni
Università degli Studi di Trieste,
Italy
2022 Rank: 77116
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2950 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 77116 | 86097 |
| Total Cites | 555 | 571 |
| H-index | 11 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 75 | 75 |
| Total Cites to Single+First Authored Papers | 92 | 92 |
| Number of Single+First+Last Authored Papers | 157 | 157 |
| Total Cites to Single+First+Last Authored Papers | 329 | 336 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 329 | 341 |
| Ratio of Total Citations to Distinct Citing Papers | 1.69 | 1.67 |
| Self-Citation Percentage |
2.80%
|
|
Sava, Gianni
Università degli Studi di Trieste,
Italy
2021 Rank: 76661
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2778 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 76661 | 85808 |
| Total Cites | 942 | 971 |
| H-index | 15 | 15 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 5 | 6 |
| Number of Single+First Authored Papers | 75 | 75 |
| Total Cites to Single+First Authored Papers | 128 | 130 |
| Number of Single+First+Last Authored Papers | 156 | 156 |
| Total Cites to Single+First+Last Authored Papers | 583 | 594 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 562 | 576 |
| Ratio of Total Citations to Distinct Citing Papers | 1.68 | 1.69 |
| Self-Citation Percentage |
2.99%
|
|
Sava, Gianni
Università degli Studi di Trieste,
Italy
2020 Rank: 42110
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Inorganic & Nuclear Chemistry
Rank in SubField 1: 1479 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42110 | 46422 |
| Total Cites | 953 | 1012 |
| H-index | 15 | 16 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 75 | 75 |
| Total Cites to Single+First Authored Papers | 146 | 154 |
| Number of Single+First+Last Authored Papers | 156 | 156 |
| Total Cites to Single+First+Last Authored Papers | 634 | 661 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 526 | 545 |
| Ratio of Total Citations to Distinct Citing Papers | 1.81 | 1.86 |
| Self-Citation Percentage |
5.83%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.